T he inflammatory bowel diseases (IBDs), Crohn's disease (CD) and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract of unknown etiology. 1 However, evidence derived from epidemiologic and family studies indicate that genetic factors play an important role in susceptibility to IBD. The genetic basis of IBD has been found to be complex and multigenic, and it does not follow a Mendelian inheritance. 2 In addition, identification of the relevant genes for IBD is hampered by genetic heterogeneity, clinical heterogeneity, and complex gene-environment interactions. In this regard, it is possible that what is recognized as IBD represents a spectrum of disorders characterized by intestinal inflammation and resulting from different pathogenic mechanisms rather than a single disease entity.
One approach to define the complex genetic basis of IBD is genome-wide searches in families with multiple affected family members. This approach has led to the identification of a large number of genetic loci that are considered to harbor susceptibility genes. The gene defect in one of the loci (IBD1) 3 has recently been defined as a gene encoding a protein related to the nuclear factor B signaling pathway (NOD-2 or CARD15) 4, 5 and is estimated to be present in 15%-20% of patients with CD.
An alternative approach to the detection of genetic factors in complex genetic traits, including IBD, is the identification of disease-related genetic loci in rodent models. Important advantages of genetic analysis of animal models include the absence of genetic and clinical heterogeneity, controlled environmental influences, the ability to analyze a large sample size, and, once a gene has been identified, systematic analysis of gene function. Although this approach has been shown to be very fruitful for several immune-mediated disorders, including diabetes mellitus, rheumatoid arthritis, and systemic lupus erythematosus, 6 it has not extensively been applied to the genetic dissection of IBD. One potentially fruitful area in which this approach can be applied is a model of colitis induced by intrarectal administration of the haptenating agent trinitrobenzene sulfonic acid (TNBS). 7 This "induced" model has some similarities to human CD because in certain mouse strains it is also due to a well-characterized Th1 T-cell-mediated inflammation and because it has a clear-cut genetic basis. The latter is indicated by the fact that it displays strain specificity; for example, the SJL/J strain is highly susceptible to disease, whereas the C57BL/6 strain, when kept under identical circumstances, is highly resistant. This introduces the possibility that genetic analysis of TNBS-induced colitis might lead to the identification of genes critical to the immunologic factors determining such susceptibility/ resistance, which may in turn relate to immunologically relevant disease genes in humans.
We have conducted such a genetic study of TNBSinduced colitis using genome-wide microsatellite methodology to identify genetic loci in (SJL/JxC57BL/6)F2 generation intercrosses. The data obtained allowed identification of 2 highly significant loci, one on chromosome 9 and the other on chromosome 11. In addition, we provide evidence that the region on chromosome 11 contains a gene(s) that plays a key role in determining the interleukin (IL)-12 response, providing a physiologic framework for these genetic findings.
Materials and Methods

Mice
Specific pathogen-free, 5-6-week-old male SJL/J and C57BL/6 mice were obtained from the National Cancer Institute. (C57BL/6xSJL/J)F1 hybrids (using the convention of female ϫ male to indicate strain parentage) and C57BL/10 mice were obtained from Jackson Laboratories (Bar Harbor, ME). Reciprocal (SJL/JxC57BL/6)F1 hybrids were generated in our facility by mating C57BL/6 male mice with SJL/J female mice. A total of 385 F2 mice (189 female and 196 male) were derived from brother-sister mating (C57BL/6xSJL/J)F1 and (SJL/JxC57BL/6)F1 mice. Mice were maintained in the National Institute of Allergy and Infectious Diseases animal holding facilities. Animal use adhered to National Institutes of Health Laboratory Animal Care Guidelines.
Reagents
Lipopolysaccharide (LPS) from Salmonella enteritidis was obtained from Sigma (Sigma-Aldrich, St. Louis, MO). Serum amyloid A (SAA) and endotoxin levels were determined using commercially available enzyme-linked immunosorbent assay kits (Biosource, Camarillo, CA, and BioWhittaker, Walkersville, MA, respectively) following the recommendations of the manufacturer. Serum IL-12 p40, p70, and tumor necrosis factor ␣ enzyme-linked immunosorbent assay kits were derived from PharMingen (PharMingen, San Diego, CA).
Induction of TNBS Colitis
For the induction of colitis, mice were first lightly anesthetized with metofane (methoxyflurane; Pitman-Moore, Mundelein, IL). To induce colitis, 3.15 mg TNBS (Sigma Chemical Co., St. Louis, MO) was mixed and dissolved with an equal amount of 100% ethanol. A total volume of 150 L of the TNBS-ethanol mixture was slowly administered per rectum via a 3.5F catheter equipped with a 1-mL syringe. To ensure distribution of TNBS within the entire colon and cecum, mice were held in a vertical position for 30 seconds after the injection. The mice were killed 4 days after induction of colitis.
Clinical Evaluation and Definition of Disease
Susceptibility to and severity of TNBS-induced colitis in F2 mice was determined by daily monitoring of clinical signs of colitis and amount of weight loss as well as measurement of SAA levels and histologic analysis when the mice were killed.
Mice that died during the first 24 -48 hours were excluded from further analysis, because it cannot be excluded that this early death was due to toxicity or perforation rather than severe colitis. Also, because C57BL/6 mice lose an average of 10% of their body weight during the first 24 hours after induction of colitis (due to anesthesia and chemical irritation of the intestinal wall), F2 mice that did not lose at least this amount were also excluded from further analysis.
Histologic Assessment of Tissues
Colonic and cecal tissue specimens obtained 4 days after induction of colitis were fixed in 10% buffered formalin phosphate (Sigma-Aldrich). The specimens were then embedded in paraffin, cut into sections, and stained with H&E. The degree of inflammation on microscopic cross sections of the colon was graded semiquantitatively from 0 to 4 as described previously 8 : 0, no evidence of inflammation; 1, low level of lymphocyte infiltration with infiltration seen in Յ10% highpower fields and no structural changes observed; 2, moderate lymphocyte infiltration with infiltration seen in 10%-25% high-power fields, crypt elongation, bowel wall thickening that does not extend beyond the mucosal layer, and no evidence of ulceration; 3, high level of lymphocyte infiltration with infiltration seen in 25%-50% high-power fields, high vascular density, and thickening of the bowel wall that extends beyond the mucosal layer; 4, marked degree of lymphocyte infiltration with infiltration seen in Ն50% high-power fields, high vascular density, crypt elongation with distortion, and transmural bowel wall thickening with ulceration.
For semiquantitative scoring of the degree of inflammation, we analyzed cross sections of the colon because in our hands the colitis score was more reproducible than the abnormalities in the cecum.
Genotyping
Spleens were taken from all mice and frozen at Ϫ70°C. DNA was isolated using a commercial kit as described by the manufacturer (Gentra Systems, Minneapolis, MN). Primers for the microsatellite markers were purchased from Research Genetics (Huntsville, AL). To evaluate which markers cosegregate with disease phenotype, 206 mice with the most distinct phenotypes were selected for a genome-wide screen: 74 most-resistant F2 mice (33 females and 41 males) as well as 132 F2 mice (43 females and 89 males) exhibiting severe colitis. Genetic regions that showed suggestive or significant linkage were then further investigated by genotyping the remainder of the eligible mice. At the start of the study, no published data were available on microsatellite markers that distinguish between the SJL/J and C57BL/6 strains. Therefore, a large number of markers were screened to generate a genetic map with locus distance between 10 -20 cM. As a result of this screen, 118 microsatellite markers equally dispersed along the mouse autosomes and the X chromosome were selected for genotypic analysis. Markers used in this study will be published online (http://www.immunogenetics.nl). MapManager was used to construct a linkage map covering the 19 murine autosomes and the X chromosome. The mean spacing between markers was 13 Ϯ 7 cM. The order and distances of the selected markers were similar to published data (http://www.informatics.jax.org).
Polymerase chain reaction amplification was performed in a GeneAmp PCR System 9600 (PE Applied Biosystems, Foster City, CA) in 96-well plates in 20-L volumes using a protocol provided by the manufacturer (Research Genetics). Forty cycles of 94°C for 45 seconds, 55°C for 45 seconds, and 72°C for 60 seconds followed by an extension period at 72°C for 7 minutes were generally used, although some primers required a slightly different annealing temperature for optimum amplification. After polymerase chain reaction amplification, polymerase chain reaction products were run on 4% agarose gels (in a mixture of 3% low melting agarose [NuSieve; BioWhittaker], and 1% SeaKem agarose [BioWhittaker] ) and visualized by ethidium bromide staining. Each plate consisted of the following internal controls: DNA from SJL/J, C57BL/6, and F1 mice as well as a no-DNA template. All double recombinants were reamplified.
In addition, the accuracy of genotyping was analyzed and confirmed by genetic analysis of microsatellite markers linked to coat-color genes on chromosomes 7 (the albino locus) 9 and 2 (the agouti locus 10 ).
Statistical Analysis
The MapManager software package was used to construct linkage maps with microsatellite markers that experimentally showed polymorphism between the SJL/J and C57BL/6 strain (http://www.mcbio.med.buffalo.edu/mapmgr.html).
For nonparametric linkage analysis of resistant and susceptible mice, 2 analysis was performed using GraphPad InStat version 3.00 for Windows 95 (GraphPad Software, San Diego, CA; http://www.graphpad.com). A 2 test statistic for each marker locus was derived using 2 ϫ 3 or 3 ϫ 3 contingency tables to test for linkage. Logarithm of the odds scores were calculated as 2 /2ln (10) .
Published criteria for suggestive and definitive linkage were applied. 11 Because the phenotypic data indicated a dominant mode of inheritance, the P values for suggestive and significant linkage were 2.4 ϫ 10 Ϫ3 and 7.2 ϫ 10 Ϫ4 , respectively. For genetic loci that exceeded the threshold for significant linkage in a genome-wide screen, locus names are proposed.
For analysis of serum IL-12 responses, the Mann-Whitney U test was applied (GraphPad Software).
Results
Disease Phenotypes in Parental Strains and Their Hybrids
As previously described, SJL/J mice reared under the specific pathogen-free conditions in our animal facility were highly susceptible to TNBS-induced colitis. 8 Thus, when given TNBS, all mice in this mouse strain quickly developed diarrhea accompanied by severe weight loss (average, 22% Ϯ 4% of body weight 4 days after induction of colitis) ( Figure 1A ). In addition, all affected mice showed severe macroscopic and microscopic disease (grade 3 or 4 on a scale of 4) at this time ( Figure  1B ), accompanied by elevated SAA levels at or above the upper detection limit of the assay (4000 ng/mL).
In contrast, C57BL/6 mice reared under the same conditions were highly resistant to TNBS-induced colitis. Thus, although mice of this strain also developed weight loss when given TNBS (typically 10%-15%) during the first 24 hours after administration of TNBS, they quickly recovered; by day 4, 90% of mice regained their original weight ( Figure 1A ). In addition, by this time, their colons looked normal both macroscopically and histologically (histologic score of 0 or occasionally 1) ( Figure 1B ) and their SAA levels were normalized below the detection limit.
As also shown in Figure 1A , 80% of (C57BL/6xSJL/ J)F1 mice developed clinical signs of colitis, indicating a dominant mode of inheritance. However, the average weight loss was only 16% Ϯ 4% at day 4. In addition, as shown in Figure 1B , a grade 2 or 3 colitis was histologically seen and the average SAA level was 1786 Ϯ 234 ng/mL.
Finally, as shown in Figure 1C , F2 mice exhibited a spectrum of disease, varying from complete resistance (similar to the C57BL/6 strain) to highly susceptible to colitis (similar to the SJL/J strain). As can be seen in Figure 1C , however, the colitis susceptibility trait followed an essentially nonnormal distribution. In the 385 F2 mice (189 female and 196 male), susceptibility to disease was inherited as a discrete rather than a continuous trait. Based on clinical phenotype, weight loss, histology, and SAA levels, 3 distinct phenotypes could be distinguished.
Group 1 (n ϭ 71) was resistant to colitis; thus, at the time these mice were killed, they showed no clinical signs of colitis, had recovered weight (average weight loss at day 4, Ϫ2.4% Ϯ 4.6%), and showed no histologic or serologic abnormalities. Group 2 (n ϭ 40) developed weight loss and clinical signs of colitis during the first 3 days but then showed signs of recovery. At the time these mice were killed, no or mild clinical and macroscopic signs of colitis were observed. Weights of mice in this group had not completely normalized (average weight loss, Ϫ13.3% Ϯ 4.6%) at the time they were killed, but the mice were gaining weight at this time. Histopathologically, some signs of colitis were seen (average score, 1.3 Ϯ 0.3). SAA levels were 1206 Ϯ 794 ng/mL. In a separate series of experiments, when mice with this behavior were killed at day 7, they had completely recovered (results not shown). Therefore, these mice were considered resistant to TNBS-induced colitis and combined with group 1 mice in part of the statistical analysis. The third group (n ϭ 197) included mice that exhibited severe diarrhea accompanied by ongoing weight loss (average weight loss, Ϫ23.1% Ϯ 3.9%), serum SAA levels Ͼ4000 ng/mL, and histologically grade 3 or 4 colitis. The remaining mice were not subject to evaluation due to either early death or failure to develop initial weight loss as described in Materials and Methods.
In general, there was an excellent correlation between clinical signs of colitis, weight loss, histopathologic findings, and SAA levels in F2 mice. Thus, the correlation coefficient between weight loss and SAA as well as between weight loss and histologic findings was 0.8 (P Ͻ 0.0001).
The incidence of colitis in F2 mice was similar in male and female mice. However, it must be noted that the number of female mice that died during the course of the study was higher than in male mice (38 vs. 23). This is most likely attributable to the fact that female mice have a lower body weight, making them more susceptible to the severe wasting and weight loss associated with TNBS-induced colitis.
No difference was found in incidence and/or histopathologic signs of colitis between the reciprocal F1 crosses, excluding a significant role for the influence of mitochondrial genes. 
Identification of Susceptibility Loci on Chromosomes 9 and 11
To evaluate which markers cosegregate with disease phenotype, 206 mice with the most distinct phenotypes were selected for a genome-wide screen: 74 mostresistant F2 mice (33 females and 41 males) and 132 F2 mice (43 females and 89 males) exhibiting severe colitis. Because the disease exhibited a nonnormal distribution, nonparametric statistical analysis was required. The significance of each difference in allele frequency between resistant and susceptible mice was calculated using the 2 test and plotted as the 2 for each marker tested. As can be seen in Figure 2 , high 2 values were seen at chromosome 9, indicating that this chromosome harbors a gene or genes associated with susceptibility to colitis. The most significant association was found with microsatellite markers D9Mit269 (at 43 cM) and marker D9Mit196 (at 48 cM) (P Ͻ 0.0001; 2 ϭ 23.2), corresponding to a logarithm of the odds score of 5.1. The strength of the association with these loci exceeded the threshold for significant linkage in a genome-wide screen. 9 This chromosomal region has been designated Tnbs1.
Because it has become increasingly apparent that chromosomal regions influencing immune-mediated diseases may be influenced by sex, we stratified our data in further studies to analyze for differences in male and female mice separately. Indeed, the association with markers D9Mit269 and D9Mit196 was highly significant in male mice but only weakly significant in female mice. Because this can be due to the higher number of susceptible male mice in the initial screen, we realized the data after inclusion of the 72 remaining eligible mice. However, the overall association with the markers on chromosome 9 remained unchanged, and again only a weak and nonsignificant association was found with female mice ( 2 , 9.2; P ϭ 0.05), whereas the association in male mice remained highly significant ( 2 , 24.4; P Ͻ 0.0001; Table 1).
Given the comparable disease frequencies in F2 male and female mice but the discordant genetic association with the identified region on chromosome 9, we then searched the genome for genetic associations in female mice. A significant association was found in female mice with the region on chromosome 11 spanning the interval between 0 and 28 cM. Subsequent genotyping and statistical analysis of all eligible female mice showed that the strongest association was found with markers Phenotypically extreme F2 mice (n ϭ 206) from an intercross between susceptible SJL/J and resistant C57BL/6 mice were subjected to a genome-wide screen using 118 microsatellite markers. The significance of the genotype-frequency difference between resistant and susceptible mice was calculated for each microsatellite marker and plotted as the 2 value. D11Mit151 and D11Mit186 at 13 and 17 cM, respectively ( 2 , Ͼ25; P Ͻ 0.0001; Table 2 ), which corresponds to a logarithm of the odds score of 5.5. In contrast, no association with these markers was found in male mice ( 2 , 1.9; P ϭ 0.7), suggesting that this region is sex specific as well. The region on chromosome 11 has been designated Tnbs2.
As shown in Figure 2 , in addition to chromosomes 9 and 11, a peak was seen on chromosome 2 in our initial screen. However, genotyping and statistical analysis of all eligible mice did not retain statistical significance (P ϭ 0.05), excluding an important role for this genetic region in determining susceptibility to TNBS-induced colitis.
Because there is strong controversy as to whether human CD is associated with a particular HLA haplotype, we analyzed our group of mice with markers that are close to or within the mouse major histocompatibility complex (MHC). In accordance with other studies in animal models of colitis, no association between susceptibility to colitis and the mouse MHC region on chromosome 17 was found. In addition, no associations were found with regions on chromosome 5 (Dssc1) and chromosome 2 (Dssc2) previously identified in the dextran sulfate-induced model of colitis. 12 Interestingly, however, the region identified on chromosome 9 maps exactly to a region that has recently been implicated in susceptibility to spontaneous colitis in the SAMP1/Yit mouse. 13 
Sex Specificity of Tnbs1 and Tnbs2
The linkage data are compatible with the possibility that Tnbs1 is male specific and Tnbs2 is female specific and do not play a role in the opposite sex, or, alternatively, that they are not exclusively sex specific despite the fact that associations are stronger in one sex. If the latter but not the former were true, one would expect to find associations with the chromosome 11 marker in those male mice that are discordant for the association with the chromosome 9 region. To analyze this possibility, we compared the genotype frequencies of D11Mit186 on chromosome 11 in resistant mice that were homozygous for the SJL/J allele at position D9Mit196 with the allele frequencies of this marker in susceptible mice that were homozygous for the C57BL/6 allele at this position. The results of this analysis are summarized in Table 3 . Although the number of animals was low, a significant association was found with marker D11Mit186 in these mice, suggesting that the chromosome 11 region plays a role in male mice as well. A similar analysis in female mice was not possible because the number of female mice discordant for D11Mit186 was too low for analysis with D9Mit196. The congenic mice we are currently generating will provide a definitive answer on the sex specificity of these chromosomal regions.
IL-12 p40 Is a Candidate Gene for Tnbs2
The region on chromosome 11 showing the strongest linkage includes the IL-12 p40 gene. IL-12 is a protein comprised of 2 disulfide-linked subunits designated p35 and p40, which together form the biologically active p70 heterodimer. 14 The IL-12 genes are likely candidate genes, because IL-12 has been identified as a central mediator of both TNBS-induced colitis and human CD. 8, 15 Thus, isolated lamina propria mononuclear cells from animals with colitis produce greatly increased amounts of this cytokine and administration of monoclonal antibodies to IL-12 leads to prevention or cure of TNBS-induced colitis. 8 We therefore investigated whether SJL/J and C57BL/6 mice have a differential IL-12 response to LPS, a known strong inducer of IL-12 that is abundantly present in the gut. We injected SJL/J, C57BL/6, and F1 hybrid mice with a sublethal intraperitoneal dose of 300 g LPS. Six hours after administration, mice were bled and the biologically active IL-12 p70 was measured in the serum. As shown in Figure 3A , whereas IL-12 p70 was hardly detectable in C57BL/6 mice, SJL/J mice produced greatly increased amounts of this cytokine and F1 hybrids produced intermediate amounts. In contrast, as shown in Figure 3B , the IL-12 p40 secretion was not significantly different between strains. The difference between strains also seemed to be cytokine specific because, as shown in Figure 3C , the tumor necrosis factor ␣ response measured 90 minutes after administration of LPS did not differ significantly between strains. To exclude that the difference in IL-12 p70 secretion was due to differences in kinetics between the strains, the IL-12 values were measured at different time points. As shown in Figure 3D , the IL-12 values were higher in the SJL/J strain than in the C57BL/6 strain at all time points measured.
If this differential IL-12 response to LPS contributes to the differences in susceptibility to TNBS-induced colitis, the genetic regions identified in the TNBS screen should colocalize with genetic regions influencing the IL-12 response to LPS. To study this, F1 mice were intercrossed to generate offspring of 123 F2 mice. These mice were injected with LPS, and serum IL-12 p70 was determined 6 hours later. To control for proper injection, serum endotoxin values were measured in each F2 mouse. Seven mice did not have measurable endotoxin, most likely due to improper injection, and were excluded. All other mice had comparable endotoxin levels at 6 hours (results not shown) but showed a broad spectrum of IL-12 responses ranging from 750 to 8000 pg/mL (Figure 4) . The median IL-12 production in F2 mice was 3850 Ϯ 2450 pg/mL. The IL-12 response was higher in female than in male F2 mice (median, 4170 vs. 2000 pg/mL; P ϭ 0.0003 as measured by 2-tailed Mann-Whitney test; Figure 4 ). This suggests sex-dependent differences in production of IL-12, which is in accordance with previous observations. 16, 17 This may help to explain the strong sex influence of the chromosome 11 locus in TNBS-induced colitis.
The 15% of mice with the most extreme phenotypes were then genotyped for the microsatellite markers on chromosomes 9 and 11 used in the TNBS screen. No statistically significant association was found with the chromosome 9 locus. In contrast, as shown in Table 4 , a highly significant association with the previously identified chromosome 11 region was found. The peak of the association was with markers D11Mit186 and D11Mit86, which contains the IL-12 p40 gene and overlaps Tnbs2. Given the small number of animals, further subanalysis in male and female mice separately was not possible.
Susceptibility to TNBS-Induced Colitis and IL-12 Responses in the C57BL/10 Strain
In a separate series of experiments, we studied the susceptibility to TNBS-induced colitis in different strains of mice. As shown in Figure 5A and B, we observed that the C57BL/10 strain was highly susceptible to TNBS-induced colitis. This was unexpected because the C57BL/10 strain is closely related to the resistant C57BL/6 strain. In fact, based on microsatellite studies, the genome of the C57BL/10 strain is 99% homologous to the C57BL/6 strain. 18 Of great importance, however, one of the few genetic regions in which the C57BL/10 strain differs from the C57BL/6 strain is on chromosome 11 between microsatellite markers D11Mit110 (at 17.6 cM) and D11Mit111 (at 25 cM). 18 This chromosomal segment overlaps exactly with Tnbs2. These findings therefore confirmed the importance of this genetic region for susceptibility to colitis. In addition, because no microsatellite differences were found on chromosome 9 between the C57BL/6 and C57BL/10 strains, this experiment also shows that this region on chromosome 11 is sufficient to develop colitis independently of Tnbs1. Finally, because these experiments were performed in male mice, it supports our statistical findings that this region is not restricted to susceptibility to colitis in female mice.
In a further study, we examined if the relation between susceptibility to colitis and the IL-12 response to responses to a sublethal dose (300 g) of LPS. F2 mice showing lowest serum IL-12 p70 responses 6 hours after intraperitoneal injection of LPS (mean serum IL-12 p70, 1260 Ϯ 290 pg/mL; range, 720 -1800 pg/mL) were compared with the highest producers (mean serum IL-12 p70, 5676 Ϯ 2180 pg/mL; range, 5000 -10,000 pg/ mL). The chromosome position of each marker is expressed as distance from the telomere (in cM). SS, homozygous for the SJL/J allele; SB, heterozygous; BB, homozygous for the C57BL/6 allele.
LPS also occurs in the C57BL/10 strain, as predicted from the studies in the C57BL/6 and SJL/J strains. Thus, if the susceptibility to TNBS-induced colitis and the IL-12 response to LPS are interrelated and linked to chromosome 11, these mice would be expected to have a high IL-12 response to LPS as well. As shown in Figure  5C , comparison of the serum IL-12 response to LPS showed that serum IL-12 level in C57BL/10 mice was markedly higher than in the C57BL/6 strain and comparable with the response seen in colitis-susceptible SJL/J mice. These data lend additional support to the idea that the genetic basis of susceptibility to TNBS-induced colitis and the IL-12 response are linked.
Discussion
Family studies have provided compelling evidence that genetic factors play a major role in susceptibility to IBD. Indeed, genome-wide searches involving multiple families have led to the identification of several genetic susceptibility regions, including a strongly associated locus for CD on chromosome 16 called IBD1. By positional cloning and candidate gene approaches, 2 groups have shown that the responsible gene for the linkage with IBD1 is NOD-2, a gene encoding a protein of yet-uncertain function that is present in 10%-20% of patients. 4, 5 This important finding clears the way for new molecular studies of the basis of CD and will facilitate the identification of additional susceptibility genes. The latter goal, however, will be difficult in light of the fact that many of the other genetic susceptibility regions show relatively weak associations with IBD and operate in only a relatively small fraction of patients. In addition, it will remain a challenge to determine how all of the involved genes interact with one another and to determine whether they affect the course of disease rather than susceptibility.
One potentially powerful approach to the identification of additional genes for IBD is to conduct genetic studies of murine models of inflammation resembling human IBD because these models offer the opportunity of relating particular genes to well-characterized immunologic (or other) defects. To date, however, only a few genetic studies of mucosal inflammation have been published. The goal of the present study was to expand our knowledge of genetic factors in murine models of inflammation by taking advantage of the differences in susceptibility to a Th1 T-cell-mediated colitis known as TNBS-induced colitis in susceptible SJL/J mice and resistant C57BL/6 mice. Theoretically, such a study could provide information concerning the genetic factors that underlie Th1-driven intestinal inflammation such as that found in CD.
In these studies, we chose to identify regions associated with susceptibility by correlating SJL/J and C57BL/6 markers with disease in F2 mice. We were greatly facilitated in this approach by the surprisingly homogeneous disease phenotypes in the F2 mice, with the susceptibility/resistance to disease inherited as a dis- crete rather than a quantitative trait manifesting as no detectable disease and easily detectable disease.
A locus of susceptibility to TNBS-induced colitis was found on chromosome 9 at 43-48 cM and was designated Tnbs1. However, although this region was associated with the entire population of F2 mice, the association was far stronger in male mice than in female mice. Of interest, although this region has not been implicated in other models of autoimmune disease, it has recently been identified in a preliminary study as a susceptibility region for spontaneous colitis in SAMP1/Yit mice in which the latter are also crossed with C57BL/6 mice. 13 The colitis in SAMP1/Yit mice is distinct from TNBSinduced colitis in that it has spontaneous rather than induced onset and affects the small intestine predominantly rather than the colon. Thus, the identification of the same locus in 2 models takes on added significance as a genetic locus applicable to human IBD, particularly because SAMP1/Yit mice have a remarkable resemblance to human CD.
A second genetic region associated with susceptibility to TNBS-induced colitis was found on chromosome 11. The peak linkage identified was in a region syntenic to human chromosome 5q33-34 that has been linked to CD in at least one genome-wide screen, implying that this region may also have relevance to human CD. 19 Of interest, this locus is also associated with susceptibility to other Th1-mediated diseases such as experimental allergic encephalitis (eae6) in mice 20 and insulin-dependent diabetes mellitus (IDDM18) in humans. 21 These associations suggest that this region harbors a gene that is critical for the induction of a Th1 response. Strong support for the latter possibility comes from additional genetic linkage studies reported here. Recognizing that TNBS-induced colitis is due to a polarized IL-12-driven Th1 T-cell response that is in fact dramatically treated by administration of anti-IL-12, we tested the capacity of SJL/J mice to C57BL/6 mice to mount an LPS-induced systemic p70 IL-12 response. We found that SJL/J mice showed strikingly higher serum IL-12 responses than similarly stimulated C57BL/6 mice. In contrast, no difference between the strains was found with respect to serum tumor necrosis factor ␣ responses. This response difference echoed the previous in vitro findings of Alleva et al., who showed that among 6 strains of mice, macrophages from the SJL/J stain and the NOD strain manifested elevated IL-12 secretion on in vitro stimulation and were also cytokine specific. 22 In additional studies, we conducted a genetic analysis for loci associated with high IL-12 responses and found that a locus could be identified in F2 mice that was coextensive with the locus in chromosome 11 harboring a gene for susceptibility to TNBS-induced colitis. These data strongly suggest that the tendency to mount a high LPS-induced IL-12 response and susceptibility to TNBS-induced colitis are related and that in fact the high IL-12 response is the immunologic basis of the susceptibility. These findings were further substantiated in the C57BL/10 strain, a strain that is almost identical to the C57BL/6 strain but differs genetically from the latter in only a few regions, in particular the identified region on chromosome 11. In support of a relation between a genetically determined high IL-12 response and susceptibility to colitis, susceptibility to TNBS-induced colitis in the C57BL/10 strain was paralleled by markedly increased IL-12 responses to LPS. However, studies in congenic strains will be necessary to provide definitive evidence for the relation between susceptibility to colitis and the IL-12 response to LPS.
A genetic susceptibility locus on chromosome 11 involved in the regulation of the IL-12 response does not necessarily conflict with the fact that SJL/J mice are also susceptible to develop a Th2-mediated colitis on intrarectal exposure to oxazolone. Oxazolone-induced colitis involves the activation of very different cell types that may be under the control of other genes including but not necessary limited to that on chromosome 9.
The loci that were identified on chromosomes 9 and 11 in the present study were strongly skewed toward sex. Thus, strongest linkage was found with the chromosome 9 locus in male mice, whereas the linkage with the chromosome 11 region was only apparent in female mice. Such skewing has been noted in other models of autoimmunity, including experimental allergic encephalitis. 23 In the latter model, young female SJL/J mice are highly susceptible to experimental allergic encephalitis, and this correlated with the fact that females have antigen-presenting cells that secrete high levels of IL-12 during T-cell activation; male mice are resistant to disease, and this correlates with the fact that their antigenpresenting cells do not secrete high levels of IL-12 under similar circumstances. Although IL-12 is a central mediator for TNBS-induced colitis as well, in contrast to experimental allergic encephalitis, susceptibility to colitis is not skewed toward female sex. This suggests the possibility that a separate susceptibility gene or genes with similar effector function is operating in TNBSinduced colitis in male mice, in this case on chromosome 9. In this regard, to our knowledge, the observed differences in IL-12 secretion between male and female mice have not been observed in humans.
A second possibility, and one that is more intuitively attractive, is that neither of the loci associated with TNBS-induced colitis is truly sex specific but rather that 2 loci with the same immunologic effect are operative in both male and female mice. If this were true, one would expect that those mice that are discordant for the allele on one chromosome would show an association with the allele on the other chromosome. Unfortunately, after stratification for sex, the association with chromosome 9 in male mice and with chromosome 11 in female mice was so strong that the number of female mice discordant for the association with the chromosome 11 locus and the number of male mice discordant for the association with the chromosome 9 locus was too low for definitive analysis. In the small group of mice that were eligible for this analysis, however, a significant association was found with the opposite chromosomal locus, indicating that these loci may not be operative exclusively in one sex. In addition to this statistical finding, we show that male C57BL/10 mice are highly susceptible to TNBS-induced colitis, despite the fact that these mice seem to be genetically identical to the resistant C57BL/6 strain on chromosome 9. Because the C57BL/10 strain differs from the C57BL/6 strain on chromosome 11, this adds to the possibility that the region on chromosome 11 may be involved in susceptibility to colitis in male mice as well. The generation of congenic and bicongenic lines of the chromosome 9 and 11 loci in both male and female mice will provide a definitive answer to this question.
Many of the experimental models for immune-mediated diseases are induced by immunizing animals with a defined peptide. It is therefore not surprising that the affinity of the MHC molecules for this peptide and the efficiency of these molecules to present antigen to the T cell determine the outcome to a great extent. For example, genetic analysis of animal models for arthritis showed the strongest linkage with the MHC haplotypes. 24 In contrast, the TNBS model is not induced by immunizing with a defined peptide. In this model, the integrity of the mucosal surface is temporarily disrupted, allowing a broad array of haptenated immunologic proteins to enter the mucosa that subsequently are presented to the immune system, leading to a mucosal immune response. Therefore, it is not surprising that no strong linkage with the MHC was found in the TNBS model. In support of this, in another chemically induced model of experimental colitis (the dextran sulfate sodium model), no linkage with the MHC on mouse chromosome 17 was found. 12 Although this study has not yet been completed, genetic analysis of spontaneous colitis in the SAMP1/Yit model 13 has thus far not shown linkage with the MHC. These data imply that the MHC genes are not major determinants for susceptibility to experimental colitis, an observation in accordance with the weak and controversial associations that have been found with human CD.
One of the striking findings in this study is that the same region on chromosome 11 identified as a susceptibility locus for TNBS-induced colitis is also identified as a region containing a gene regulating the IL-12 response to LPS. Interestingly, we have identified at least 3 polymorphisms in the coding sequence of the IL-12 p40 gene between the SJL/J and the C57BL/6 strain, 2 of them leading to amino acid substitutions (G. Bouma, unpublished results, July 2001). Our sequencing results were similar to previously posted sequences (Gen Bank accession numbers M86671 and AF128215). Because, in humans, defined charged residues in both the p35 and p40 genes have been shown to be critical for the formation of the biologically active IL-12 p70 heterodimer, 25 it is tempting to speculate that these amino acid differences between the SJL/J and C57BL/6 strains alter the affinity of the p40 molecule for the p35 molecule, thereby interfering with IL-12 p70 formation. This hypothesis, which we are currently investigating, might also explain why the IL-12 p70 secretion was so dramatically different, whereas the p40 levels were comparable between the 2 strains. Although this hypothesis directly links the observed phenotypic differences to a genetic variation within the IL-12 gene, it cannot be excluded that these differences are in fact mediated through another gene that is located within the vicinity of the IL-12 p40 gene.
In conclusion, we have identified 2 genetic regions that are involved in susceptibility to experimental colitis. One of these regions is on chromosome 9 and is similar if not identical to the one found in association with another model of intestinal inflammation, the SAMP1/ Yit model, suggesting that this region harbors a gene that plays an important but as-yet unknown role in mucosal immune homeostasis. A second locus is on chromosome 11 and is also identified as a regulator of IL-12 responses, suggesting that the latter is a susceptibility factor in Th1 colitis. In view of the immunopathology of human CD, both findings may have important relevance for the genetic dissection of susceptibility to colitis and warrant further research toward the homologous regions and genes in humans. The strong differences in linkage between sexes suggest that genetic studies in humans should be stratified more stringently with respect to sex.
